You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Platelet Engraftment

Showing 1 - 25 of 3,742
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )

Recruiting
  • Hematological Disease
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Feb 6, 2023

PLT After Allogenic Hematopoietic Stem Cell Transplantation Trial (Avatrombopag, rhTPO)

Not yet recruiting
  • PLT After Allogenic Hematopoietic Stem Cell Transplantation
  • (no location specified)
Nov 21, 2021

Hematologic Malignancies Trial in Minneapolis (Romiplostim)

Completed
  • Hematologic Malignancies
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center
Jun 5, 2021

Platelet Recovery After Umbilical Cord Blood Transplantation Trial in Hefei (Avatrombopag)

Recruiting
  • Platelet Recovery After Umbilical Cord Blood Transplantation
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Apr 19, 2023

Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)

Not yet recruiting
  • Stem Cell Transplant Complications
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 17, 2022

Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

Not yet recruiting
  • Leukemia
  • +12 more
  • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
  • (no location specified)
Mar 20, 2023

Severe Aplastic Anemia Trial in Hefei (Anti-Thymocyte Globulin (Rabbit))

Recruiting
  • Severe Aplastic Anemia
  • Anti-Thymocyte Globulin (Rabbit)
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Sep 9, 2023

Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

Recruiting
  • Hematopoietic Malignancy
  • +2 more
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Nov 6, 2023

Bone Marrow Transplantation Recipient, Cord Blood Transplant Recipient, Hematopoietic Cell Transplantation Recipient Trial in

Active, not recruiting
  • Bone Marrow Transplantation Recipient
  • +2 more
  • Eltrombopag Olamine
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2022

Myeloid Hematological Malignancies Trial in Houston (Busulfan, Cyclophosphamide, Fludarabine)

Completed
Has Results
  • Myeloid Hematological Malignancies
  • Houston, Texas
    Texas Children's Hospital
May 13, 2022

Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Malignant Hematological Diseases
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Jul 3, 2023

Beta-Thalassemia Trial in Nanning (CS-101)

Recruiting
  • Beta-Thalassemia
  • CS-101
  • Nanning, China
    The First Affiliated Hospital of Guangxi Medical University
Sep 9, 2023

Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease Trial in Canada,

Completed
Has Results
  • Hemophagocytic Lymphohistiocytosis
  • +5 more
  • Hematopoietic Stem Cell Transplant
  • Birmingham, Alabama
  • +21 more
Dec 6, 2022

Beta-Thalassemia Trial (CS-101 injection)

Not yet recruiting
  • Beta-Thalassemia
  • CS-101 injection
  • (no location specified)
Sep 27, 2023

Allogeneic Hematopoietic Cell Transplantation Trial in Cleveland (Nicotinamide riboside (NR))

Recruiting
  • Allogeneic Hematopoietic Cell Transplantation
  • Nicotinamide riboside (NR)
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 17, 2023

Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Malignancy
  • CliniMACS®
  • (no location specified)
Oct 17, 2023

Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2 Trial in Melbourne (Venetoclax,

Recruiting
  • Leukemia, Myeloid, Acute
  • +5 more
  • Melbourne, Victoria, Australia
    Melbourne Health
Jun 19, 2022

Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

Recruiting
  • Primary Immune Deficiency Disorder
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University
Oct 20, 2022

Transfusion-dependent a-Thalassemia Trial (GMCN-508A Drug Product)

Not yet recruiting
  • Transfusion-dependent α-Thalassemia
  • GMCN-508A Drug Product
  • (no location specified)
Feb 24, 2023

ß-thalassemia Trial (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • (no location specified)
Mar 15, 2023

ß-thalassemia Trial in Shanghai (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • Shanghai, China
    Shanghai Ruijin Hospital
Mar 16, 2023

Hematologic Tumors Trial in Canada (Tranexamic Acid)

Recruiting
  • Hematologic Neoplasms
  • Tranexamic Acid
  • Calgary, Alberta, Canada
  • +10 more
Dec 12, 2022

Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)

Completed
Has Results
  • Multiple Myeloma
  • Stanford, California
    Stanford University
Aug 17, 2022

Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

Recruiting
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 25, 2023

Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

Completed
Has Results
  • Leukemia
  • +4 more
  • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 10, 2022